Company led recall - Nutricia Multiple Products

COMPANY LED RECALL

We have received a Recall from Danone

on Various products

Reason: Danone is recalling specific batches of Aptamil / Cow & Gate infant milk due to the possible presence of cereulide (toxin).

Please can you ensure that your stores quarantine the product listed below.

Further Information

https://www.food.gov.uk/news-alerts/alert/fsa-prin-05-2026

Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 recall-Baclofen 10mg/5ml Oral Solution

Syri Limited, T/A SyriMed is recalling batches of product as a precautionary measure due to crystallisation observed over time in the oral solution.

MHRA drug alert link:https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-syri-limited-t-slash-a-syrimed-baclofen-10mg-slash-5ml-oral-solution-el-26-a-slash-06?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ecd84602-31de-4417-ac67-2e894ecffebb&utm_content=immediately

MHRA drug alert date:03/02/26

Further Information

For medical information enquiries please use the following options:

Email: medinfo@syrimed.co.uk, or telephone +44 (0) 330 1359 422.

For stock control enquiries please email syriwholesale@bnsthamelabs.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 recall-Carmustine 100 mg Powder and Solvent for Concentrate for Solution for Infusion

Accord Healthcare limited is recalling a single batch due to an out of specification test result.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-accord-healthcare-ltd-carmustine-100-mg-powder-and-solvent-for-concentrate-for-solution-for-infusion-1-vial-100mg-powder-1-vial-of-3-ml-solvent-el-26-a-slash-05?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=bf9bdbd3-2473-4486-b6dd-04d2961a9c3c&utm_content=immediately

MHRA drug alert date: 2/2/26

Further Information

For medical information enquires please contact Accord Medical Information Department on 01271 385257 or email medinfo@accord-healthcare.com.

For stock control enquiries please contact our Customer Services Team on 0800 373573.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 3 recall-Aspar Ibuprofen tabs 200mg

Aspar Pharmaceuticals Ltd is recalling specific batches distributed in Aspar, Almus and Numark livery. The batches are being recalled as a precautionary measure following findings of foil perforations in some blisters.

Product recall date: 29/01/26

MHRA recall link:Class 3 Medicines Recall: Aspar Pharmaceuticals Ltd, Ibuprofen 200mg Tablets, Ibucalm 200mg tablets, EL(26)A/07 - GOV.UK

MHRA recall date: 04/02/26

Further Information

For all enquiries regarding this product, please call 020 8205 9846 extension 2209 or email adrian.zahra@aspar.co.uk.

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

National Patient Safety Alert: Class 1 Medicines Recall Notification: Recall of Quetiapine Oral Suspension (unlicensed medicine)

Eaststone Limited is initiating a recall of all batches of quetiapine oral suspension products due to a potential risk of overdose, which could have consequences for the safety of patients.

MHRA Drug alert date: 29/01/26

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-quetiapine-oral-suspension-unlicensed-medicine-manufactured-by-eaststone-limited-due-to-a-potential-for-overdosing-natpsa-slash-2026-slash-002-slash-mhr?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=a09ef640-89c2-4758-9ee1-2f562cdba868&utm_content=immediately#download-documents

Eaststone Limited will be contacting customers who have received affected stock directly

Further Information

For more information or stock and, please contact Eaststone Limited on +44(0)800 678 3102 (Select Option 1) or email specials@eaststone.co.uk 

For medical information queries, please contact Eaststone Limited on +44(0)800 678 3102 (Select Option 3) or email umar.ahmed@eaststone.co.uk 

For all other enquires place contact Eaststone Limited +44(0)800 678 3102 (Select Option 3) or email umar.ahmed@eaststone.co.uk 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 4 caution in use-Arixtra solution for injection, pre-filled syringes

Viatris has received reports of brown discolouration and blockage in the needle of pre-filled syringes of Arixtra. This quality defect is related to oxidation of the syringe needle.

MHRA drug alert Date: 28/1/26

MHRA drug alert link: Class 4 Medicines Defect Notification: Viatris Products Ltd, Arixtra solution for injection, pre-filled syringes, EL(26)A/04 - GOV.UK

This is a caution in use only we are not accepting stock returns

Further Information

For medical information enquiries please telephone Viatris UK Healthcare Limited Medical Information on +44 (0)1707 853 000 (select option 1) or email info.uk@viatris.com.

For stock control enquiries please contact telephone Customer Services on +44 (0)1707 853 000 (select option 2).

Class 4 caution in use-Ocumont Eye Ointment 1% w/w

Blumont Pharma Limited is reporting to the MHRA regarding the absence of Braille on the outer carton of one batch of Ocumont Eye Ointment 1% w/w (POM). It was identified that the Braille information was inadvertently omitted during the approval and release process.

MHRA drug alert Date: 27/1/26

MHRA drug alert link: Class 4 Medicines Defect Notification: Blumont Pharma Limited, Ocumont Eye Ointment 1% w/w, EL(26)A/03 - GOV.UK

This is a caution in use only we are not accepting stock returns

further information

For all medical information enquiries and information on this product, please email info@blumontpharma.com, or telephone + 44 (0)1476 978 568.

For stock control enquiries please email info@blumontpharma.com, or telephone + 44 (0)1476 978 568.

Class 3 recall- Fingolimod Glenmark 0.5 mg Hard Capsules

CLASS 3 RECALL

PLEASE READ AND CONFIRM THAT YOU HAVE RECEIVED THIS.

We have received a Class 3 Recall from Glenmark Pharmaceuticals Europe Limited on FINGOLIMOD CAP 0.5MG

MHRA drug alert link https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-glenmark-pharmaceuticals-europe-limited-fingolimod-glenmark-0-dot-5-mg-hard-capsules-el-26-a-slash-02?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=53be9484-a57c-41df-9fe0-10338d61497b&utm_content=immediately

MHRA ref: DMRC-38142990

Reason: Glenmark Pharmaceuticals Europe Limited is recalling the above batch after stability testing showed out-of-specification results. The batch is being recalled as a precautionary measure following test results that showed a delay in capsule dissolution.

Please can you ensure that your stores quarantine the product listed below.

Further Information

For all medical information enquiries and information on this product, medical_information@glenmarkpharma.com or telephone 0044 8004 580 383

For stock control enquiries please email orders.uk@glenmarkpharma.com

Please return all affected stock to your original supplier for credit. As Alliance Healthcare has not supplied the affected batch, we will not be accepting returns.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Class 2 recall-Paliperidone PR pre-filled syringe 50, 75, 100 & 150mg

Mercury Pharmaceuticals Ltd is recalling remaining stock of paliperidone pre-filled syringes as a precautionary measure due to Good Manufacturing Practice (GMP) deficiencies cited during a recent inspection at the finished product manufacturing site.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-mercury-pharmaceuticals-ltd-paliperidone-mercury-pharma-prolonged-release-suspension-for-injection-in-pre-filled-syringes-el-26-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=e99da014-d03f-4b15-9aee-619b70601394&utm_content=immediately

MHRA drug alert date: 20/01/26

Further Information

For stock enquiries please contact Advanz Pharma Customer Care Services on +44 (0) 208 588 9441 or email customercare@advanzpharma.com

For medical information enquiries please contact Advanz Pharma Medical Information on +44 (0) 208 588 9131 or email medicalinformation@advanzpharma.com

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

Nestle SMA Infant Milk - Food Standards Agency Consumer Recall Notice

Retailers of these products must display the recall notice from Nestle which can be found using this link.

Product recall date: 06/01/26

Nestlé recalls several SMA Infant Formula and Follow-On Formula as a precaution because of the possible presence of cereulide (toxin) | Food Standards Agency